Researchers examined rates of new multidrug-resistant organism colonization and healthcare-associated infections before and after a hospital move in Montréal, Canada. The move involved shifting inpatients from an older, 417-bed facility with mixed three-and four-person wards to a 350-bed facility with all private, single-patient rooms, with individual showers, toilets and easily accessible sinks. The move occurred in April 2015.
In the 36 months after the hospital move, researchers observed an immediate and sustained decrease in new VRE and methicillin-resistant Staphylococcus aureus colonization as compared to the 27 months before the move. There was also a reduction in VRE infections, from 55 before the move to 14 after.
However, there was no decrease in Clostridioides difficile or MRSA infection rates.
More articles on healthcare quality:
Viewpoint: Rural healthcare needs a transformation
406 hospitals earn ‘Leader in LGBTQ Health Care Equality’ designation
5 ways to improve pediatric care for immigrant children
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
